Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Jacob E Ollech"'
Autor:
Henit Yanai, Hadar Amir Barak, Jacob E Ollech, Irit Avni Biron, Idan Goren, Yifat Snir, Hagar Banai Eran, Yelena Broitman, Maya Aharoni Golan, Elena Didkovsky, Iris Amitay-Laish, Ayelet Ollech, Emmilia Hodak, Iris Dotan, Lev Pavlovsky
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Background and Aims: Skin eruptions are prevalent among patients with inflammatory bowel diseases (IBD), often associated with therapies and frequently leading to dermatological consults and treatment interruptions. We aimed to assess the impact of j
Externí odkaz:
https://doaj.org/article/88b32f4454734962ae309656aa9a48f8
Publikováno v:
Revista Médica Clínica Las Condes, Vol 30, Iss 5, Pp 339-343 (2019)
This article describes the need for objective treatment and management goals of inflammatory bowel disease to monitor disease course and progression. We discuss the “treat to target” or “tight control” approach as an evolving treatment strate
Externí odkaz:
https://doaj.org/article/7997b25a54254aecb539b4d09e5fb50e
Autor:
Jacob E. Ollech, Hagar Eran-Banai, Idan Goren, Tali Sharar Fischler, Irit Avni-Biron, Yifat Snir, Yelena Broitman, Shaked Cohen, Adi Friedenberg, Maor H. Pauker, Iris Dotan, Henit Yanai
Publikováno v:
Annals of Medicine, Vol 56, Iss 1 (2024)
Introduction Real-world data on tofacitinib’s effectiveness is limited and mainly retrospective or registry-based. We elected to conduct a pragmatic prospective study to assess the efficacy of tofacitinib for moderate to severe ulcerative colitis (
Externí odkaz:
https://doaj.org/article/9ed4192db3f5459abdc38b3fc00a06b6
Autor:
Irit Avni-Biron, Ervin Toth, Jacob E. Ollech, Artur Nemeth, Gabriele Wurm Johansson, Hagai Schweinstein, Reuma Yehuda Margalit, Uri Kopylov, Iris Dotan, Henit Yanai
Publikováno v:
Diagnostics, Vol 14, Iss 16, p 1733 (2024)
Introduction: Complicated perianal disease (cPD) may be the sole presentation of Crohn’s disease (CD). The role of small-bowel capsule endoscopy (SBCE) in the diagnostic algorithm of cPD is unclear. We aimed to evaluate the role of SBCE as a diagno
Externí odkaz:
https://doaj.org/article/fd9c9713fb494a6e9a931efa8fe9ae7a
Autor:
Keren Masha Rabinowitz, Michal Navon, Hadar Edelman-Klapper, Eran Zittan, Ariella Bar-Gil Shitrit, Idan Goren, Irit Avni-Biron, Jacob E. Ollech, Lev Lichtenstein, Hagar Banai-Eran, Henit Yanai, Yifat Snir, Maor H. Pauker, Adi Friedenberg, Adva Levy-Barda, Arie Segal, Yelena Broitman, Eran Maoz, Baruch Ovadia, Maya Aharoni Golan, Eyal Shachar, Shomron Ben-Horin, Nitsan Maharshak, Michal Mor, Haim Ben Zvi, Rami Eliakim, Revital Barkan, Tali Sharar-Fischler, Sophy Goren, Noy Krugliak, Edward Pichinuk, Michael Mor, Michal Werbner, Joel Alter, Hanan Abu-Taha, Kawsar Kaboub, Moshe Dessau, Meital Gal-Tanamy, Dani Cohen, Natalia T. Freund, Iris Dotan, on behalf of the Responses to COVID-19 Vaccine Israeli IBD Group
Publikováno v:
Vaccines, Vol 10, Iss 8, p 1186 (2022)
Patients with inflammatory bowel disease (IBD) treated with anti-tumor-necrosis factor-alpha (TNFα) exhibited lower serologic responses one-month following the second dose of the COVID-19 BNT162b2 vaccine compared to those not treated with anti-TNF
Externí odkaz:
https://doaj.org/article/002599bbb4e74664a74f8cb9e8c3051d
Autor:
Lev Lichtenstein, Benjamin Koslowsky, Ami Ben Ya’acov, Irit Avni-Biron, Baruch Ovadia, Ofer Ben-Bassat, Timna Naftali, Uri Kopylov, Yael Haberman, Hagar Banai Eran, Rami Eliakim, Adi Lahat-Zok, Ayal Hirsch, Eran Zittan, Nitsan Maharshak, Matti Waterman, Eran Israeli, Idan Goren, Jacob E. Ollech, Henit Yanai, Bella Ungar, Benjamin Avidan, Dana Ben Hur, Bernardo Melamud, Ori Segol, Zippora Shalem, Iris Dotan, Selwyn H. Odes, Shomron Ben-Horin, Yf’at Snir, Yael Milgrom, Efrat Broide, Eran Goldin, Shmuel Delgado, Yulia Ron, Nathaniel Aviv Cohen, Eran Maoz, Maya Zborovsky, Safwat Odeh, Naim Abu Freha, Eyal Shachar, Yehuda Chowers, Tal Engel, Hila Reiss-Mintz, Arie Segal, Adar Zinger, Ariella Bar-Gil Shitrit
Publikováno v:
Vaccines, Vol 10, Iss 3, p 376 (2022)
Background: Crohn’s disease (CD) and ulcerative colitis (UC) are chronic, immune-mediated inflammatory bowel diseases (IBD) affecting millions of people worldwide. IBD therapies, designed for continuous immune suppression, often render patients mor
Externí odkaz:
https://doaj.org/article/eca69cf35e7040a98fb236c6175f11ed
Autor:
Jacob E, Ollech, Henit, Yanai, Irit, Avni-Biron, Yifat, Snir, Hagar, Banai, Revital, Barkan, Lihi, Godny, Nir, Wasserberg, Ian, White, Iris, Dotan
Publikováno v:
American Journal of Gastroenterology. 118:367-370
Whether fecal calprotectin (FC) and quality of life (QoL) questionnaires reflect change in disease activity in patients with a J-pouch is unknown.Patients with acute pouchitis were prospectively treated with a 2-week course of antibiotics. The full P
Autor:
Irit Avni‐Biron, Tali Mishael, Eran Zittan, Moran Livne‐Margolin, Adar Zinger, Roie Tzadok, Rosie Goldenberg, Uri Kopylov, Yulia Ron, Eran Hadar, Sarit Helman, Sorina Grisaru Granovsky, Jacob E. Ollech, Ayelet Arazi, Rivka Farkash, Maor H. Pauker, Henit Yanai, Iris Dotan, Ariella Bar‐Gil Shitrit
Publikováno v:
Alimentary Pharmacology & Therapeutics. 56:1361-1369
Women with inflammatory bowel diseases (IBD) often receive biologics to maintain remission during pregnancy.To assess maternal and neonatal outcomes in patients with IBD treated with ustekinumab (UST) during pregnancy METHODS: In a multicentre, prosp
Autor:
Yanai, Irit Avni Biron, Lior Hayat, Jacob E. Ollech, Hagar Banai-Eran, Bar Narkis, Ohad Houri, Maor H. Pauker, Vardit Shay, Iris Dotan, Eran Hadar, Henit
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 12; Pages: 4120
Background: Inflammatory bowel disease (IBD) can have an impact on pregnancy outcomes due to the effect of the disease activity and medication use. This study aimed to evaluate the pregnancy outcomes in IBD patients treated at a multidisciplinary cli
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 7; Pages: 2544
Background and aims: With the development of narrow-band imaging (NBI) in the endoscopic evaluation of patients with Barrett’s esophagus (BE), the role of random biopsies according to the Seattle protocol (SP) has been questioned. We aim to compare